Skip to search
Skip to main content
Back to Search
Start Over
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
Authors :
Rubin, David T Allegretti, Jessica R Panés, Julián Shipitofsky, Nicole Yarandi, Shadi S Huang, Kuan-Hsiang Gary Germinaro, Matthew Wilson, Rebbecca Zhang, Hongyan Johanns, Jewel Feagan, Brian G Hisamatsu, Tadakazu Lichtenstein, Gary R Bressler, Brian Peyrin-Biroulet, Laurent Sands, Bruce E Dignass, Axel Abrahamovych, Orest Abu-farsakh, Niazy Afanasieva, Halyna Akpinar, Hale Al Kharrat, Houssam Altintas, Engin Altwegg, Romain Andreev, Pavel Aomatsu, Kazuki Araki, Hiroshi Argollo, Marjorie Ariel, Federico Armuzzi, Alessandro Ashida, Toshifumi Augustyn, Monika Aumais, Guy Azum, Martín Baert, Filip Balaz, Jozef Balderramo, Domingo Begun, Jakob Berova, Temenuzhka Billiauws, Lore Blanco, Antonio Bortlik, Martin Bossa, Fabrizio Bunkova, Elena Cabello, Mercedes Cao, Qian Caprioli, Flavio Cerqueira, Rute Chachu, Karen Chamouard, Patrick Chen, Chunxiao Chen, Yan Chen, Baili Chen, Dongfeng Chen, Hong Chen, Youxiang Chen, Chou-chen Cheon, Jaehee Chen, Minhu Chiu, Cheng-tang Choi, Changhwan Chow, Elizabeth Cicala, Michele Cintra, Aderson Danilkiewicz, Wit Datsenko, Olena De Hertogh, Gert De María, Julio Del Valle Torrealba Medina, Leyanira Deliang, Liu Desreumaux, Pierre Dewint, Pieter Ding, Shigang Doherty, Glen Draganova, Raina Dutré, Joris Duvall, George Egan, Laurence Fahed, Julien Fechner, Lars Fedurco, Miroslav Ferhat Celik, Aykut Fernandez, Juan Filip, Rafal Fishman, Sigal Flores, Cristina Fogel, Ronald Fowler, Sharyle Francesconi, Carlos Fujii, Toshimitsu Fujiya, Mikihiro Fukata, Masayuki Fukuhara, Seiichiro Furumoto, Yohei G.Kiss, Gyula Gachowski, Waldemar Gao, Xiang Gasbarrini, Antonio Gawdis-wojnarska, Beata Gaya, Daniel Geccherle, Andrea Gilletta De Saint Joseph, Cyrielle Gimenez, Edgardo Gionchetti, Paolo Goldin, Eran Golovchenko, Oleksandr Gonciarz, Maciej Gonen, Can Gonzales, Chad Gonzalez, Raquel Gonzalez Segura, Gaston Julian Gridnyev, Oleksiy Gu, Fang Gupta, Nitin Gyokeres, Tibor Haines, Melissa Hebuterne, Xavier Hedin, Charlotte Hellstrom, Per Hilmi, Ida Normiha Hirai, Fumihito Hisabe, Takashi Hlavaty, Tibor Hoentjen, Frank Holtmann, Gerald Horiki, Noriyuki Horny, Ivo Horvat, Gyula Horvath, Frantisek Hoshi, Namiko Hosomi, Shuhei Hospodarskyy, Ihor Hou, Xiaohua Hrdlicka, Ludek Hu, Naizhong Huang, Vivian Huang, Caibin Inaba, Tomoki Ishiguro, Yoh Ishihara, Shunji Ishikawa, Takeshi Iskandar, Heba Israeli, Eran Itaba, Soichi Ivanishyn, Olha Izbéki, Ferenc Jain, Animesh Jairath, Vipul Jang, Byung Ik Jiang, Chunmeng Jones, Michael Kagaya, Takashi Kalimullina, Dilara Karakina, Marina Karatas, Ali Kashimura, Hiroshi Keret, Dan Khovaeva, Yaroslava Kierkus, Jaroslaw Kim, Taeoh Kim, Youngho Kim, Hyo Jong Klaus, Jochen Kleczkowski, Dariusz Klopocka, Maria Kobayashi, Taku Kobielusz-gembala, Iwona Kojima, Yuichiro Koo, Ja Seol Kopon, Adam Kopp, James Koyama, Fumikazu Koynarski, Vasil Kravchenko, Tetiana Kudo, Masatoshi Kusunoki, Ryusaku Kwon, Kwangan Laclav, Martin Lago, Paula Laharie, David Lasa, Juan Lateef, Syed Latinovic Radakovic, Tatjana Lee, Kang Moon Leszczyszyn, Jaroslaw Li, Yan Liu, Mei Liu, Eashen Lobaton Ortega, Triana Lopatin, Denis Lopes, Susana Lovric Jovanovic, Mileva Lubini, Marcio Lukas, Milan Maaser, Christian Machytka, Evzen Maemoto, Atsuo Magro, Fernando Marcet, Jorge Marini, Eduardo Marusawa, Hiroyuki Matous, Jan Matsumoto, Takayuki Mendu, Shoba Miao, Yinglei Mihaly, Emese Miheller, Pal Ministro, Paula Miyabayashi, Hideharu Mohl, Wolfgang Molnar, Martin Moore, Gregory Moran Faienzo, Gabriela Morral, Eugeni Domenech Motoya, Satoshi Murali, Narayanachar Mustaffa, Nazri Mohamad Naem, Mohamed Nakai, Katsuhiko Nakajima, Koichi Nakamoto, Yasunari Nakamura, Masanao Nancey, Stephane Navaneethan, Udayakumar Nawawi, Khairul Najmi Muhammad Ninomiya, Tomoyuki Novak, Janos Oki, Motoji Oliveira Santana, Genoile Onizawa, Michio Ono, Yohei Osada, Taro Osipenko, Marina Owczarek, Danuta Parente, Jose Miguel Patel, Kamal Patel, Bhaktasharan Pedersen, Peder Petroniene, Rima Petrov, Asen Petrova, Elina Piquet, Marie-astrid Pokrotnieks, Juris Poroshina, Elena Portela, Francisco Pruthi, Jatinder S. Prystupa, Lyudmila Pukitis, Aldis Qiu, Yun Rafalsky, Vladimir Rainis, Tova Ramos Junior, Odery Rashid, Mohammed Rayyan, Yasser Reshetko, Olga Ribeiro, Tarsila Rivero, Montserrat Roblin, Xavier Romatowski, Jacek Rowbotham, David Ruffinengo, Orlando Enrique Rydzewska-wyszkowska, Grazyna Sablin, Oleg Sai, Souken Saibeni, Simone Said, Rosaida Hj. Md. Sakuraba, Hirotake Samaan, Mark Sandborn, William Saruta, Masayuki Sauk, Jenny Savarino, Edoardo Vincenzo Schultz, Michael Schulze, Joerg Sedghi, Shahriar Seidler, Ursula Seksik, Philippe Senturk, Omer Shelton, Edward Shimizu, Masahito Shin, Sungjae Shukla, Richa Sigal, Michael Silva Junior, Roberto Simoes Neto, Joaquim Siroky Jr., Milan Smajstrla, Vit Smid, Vaclav Smiley, Sarah Soledad Brunatto, Luciana Stanislavchuk, Mykola Stokesberry, David Stone, Christian Suiter, Daniel Suzuki, Takayoshi Svorcan, Petar Takagi, Sho Takagi, Tomohisa Takamura, Masaaki Takayama, Tetsuji Takeuchi, Ken Tanaka, Akihito Tanaka, Hiroki Tanash, Omar Tang, Wen Tankova, Ludmila Teixeira Campos, Luciana Thin, Lena Tkachev, Alexander Tolmanis, Ivars Tsarynna, Nataliia Tsonev, Nikolay Tulassay, Zsolt Ueo, Tetsuya Unal, Nalan Valuyskikh, Ekaterina Van Dop, Willemijn Vasilevskaya, Olga Venugopal, Kannan Verstockt, Bram Viamonte, Manuel Vyshyvanyuk, Vira Wang, Bangmao Wang, Xiaoyan Wang, Jiangbin Wang, Yufang Wei, Shu-chen Weisshof, Roni Wisam, Sbeit Wojcik, Katarzyna Yakovlev, Alexey Yasuda, Hiroshi Ye, Byongduk Yen, Hsu-heng Yilmaz, Hasan Yokoyama, Yoko Yoon, Hyuk Yoshida, Takeshi Yurkiv, Andriy Zaha, Osamu Zaltman, Cyrla Zhan, Qiang Zhang, Hongjie Zhang, Shutian Zhu, Lanxiang Zou, Duowu Zou, Xiaoping Zureikat, Firas
Source :
The Lancet; January 2025, Vol. 405 Issue: 10472 p33-49, 17p
Publication Year :
2025
Abstract
Interleukin-23 inhibition is effective in treating ulcerative colitis. Guselkumab is a dual-acting, human IgG1, interleukin-23p19 subunit inhibitor that potently neutralises interleukin-23 and can bind to CD64. We aimed to evaluate the efficacy and safety of guselkumab as induction and maintenance therapy in patients with ulcerative colitis.
Details
Language :
English
ISSN :
01406736 and 1474547X
Volume :
405
Issue :
10472
Database :
Supplemental Index
Journal :
The Lancet
Publication Type :
Periodical
Accession number :
ejs68479635
Full Text :
https://doi.org/10.1016/S0140-6736(24)01927-5